Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $315.59 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $166.68 | 4 | $0 (2019) |
| Grifols USA, LLC | $61.39 | 3 | $0 (2018) |
| Novo Nordisk Inc | $49.55 | 1 | $0 (2019) |
| Allergan Inc. | $23.80 | 2 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $14.17 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $139.25 | 2 | AstraZeneca Pharmaceuticals LP ($89.70) |
| 2018 | $90.14 | 3 | AstraZeneca Pharmaceuticals LP ($55.40) |
| 2017 | $86.20 | 6 | Grifols USA, LLC ($26.65) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $89.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/08/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $49.55 | General |
| Category: Diabetes | ||||||
| 10/23/2018 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Pulmonology | ||||||
| 10/02/2018 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Pulmonology | ||||||
| 07/17/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $55.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/21/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/26/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: DIABETES | ||||||
| 05/18/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/22/2017 | Grifols USA, LLC | Prolastin-C (Biological) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Pulmonology | ||||||
| 02/22/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 12 | 390 | 409 | $26,757 | $8,342 |
| 2021 | 40 | 3,695 | 6,832 | $370,243 | $179,971 |
| 2020 | 41 | 3,328 | 5,964 | $320,034 | $147,136 |
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 76 | $10,640 | $3,808 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 41 | $3,936 | $1,515 | 38.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 23 | 24 | $3,288 | $711.62 | 21.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 12 | 13 | $1,092 | $587.99 | 53.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 59 | 61 | $1,830 | $473.97 | 25.9% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 41 | 42 | $1,974 | $355.32 | 18.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 16 | 16 | $832.00 | $214.24 | 25.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 19 | 19 | $1,121 | $200.64 | 17.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 21 | 21 | $861.00 | $198.71 | 23.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 64 | 67 | $536.00 | $198.33 | 37.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 13 | $455.00 | $42.76 | 9.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 14 | 16 | $192.00 | $36.00 | 18.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 319 | 913 | $127,820 | $72,602 | 56.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 234 | 480 | $46,080 | $29,968 | 65.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 118 | 118 | $16,520 | $14,435 | 87.4% |
| 87428 | Sarscov & inf vir a&b ag ia | Office | 2021 | 70 | 86 | $11,782 | $6,247 | 53.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 305 | 760 | $22,800 | $5,839 | 25.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2021 | 259 | 547 | $25,709 | $4,570 | 17.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 32 | 32 | $6,240 | $4,522 | 72.5% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 19 | 20 | $5,600 | $4,106 | 73.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 221 | 237 | $12,324 | $3,143 | 25.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 123 | 327 | $13,407 | $3,124 | 23.3% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 110 | 110 | $5,776 | $2,966 | 51.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 220 | 276 | $16,284 | $2,897 | 17.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 320 | 942 | $7,536 | $2,780 | 36.9% |
About Dr. Kunthavai Patel, M.D
Dr. Kunthavai Patel, M.D is a Specialist healthcare provider based in Houston, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1891776530.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kunthavai Patel, M.D has received a total of $315.59 in payments from pharmaceutical and medical device companies, with $139.25 received in 2019. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($315.59).
As a Medicare-enrolled provider, Patel has provided services to 7,413 Medicare beneficiaries, totaling 13,205 services with total Medicare billing of $335,450. Data is available for 3 years (2020–2022), covering 93 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Houston, MS
- Active Since 11/09/2005
- Last Updated 01/24/2019
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1891776530
Products in Payments
- FARXIGA (Drug) $166.68
- Tresiba (Drug) $49.55
- Prolastin-C Liquid (Biological) $34.74
- Prolastin-C (Biological) $26.65
- TOUJEO (Drug) $14.17
- DALVANCE (Drug) $13.04
- TEFLARO (Drug) $10.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Houston
Daniel Tung, M.d, M.D
Specialist — Payments: $1.0M
Dr. James Welsh, Md, MD
Specialist — Payments: $432,652
Dr. Amin Jamal, M.d.,P.a, M.D.,P.A
Specialist — Payments: $264,808
Dr. Rosa Tang, M.d, M.D
Specialist — Payments: $248,234
Dr. Stephen Mahoney, M.d, M.D
Specialist — Payments: $191,264
Dr. Fiaz Zaman, M.d, M.D
Specialist — Payments: $172,386